These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Target/therapies for chronic recurrent erythema nodosum leprosum.
    Author: Thangaraju P, Varthya SB, Venkatesan S.
    Journal: Indian J Pharmacol; 2020; 52(3):222-226. PubMed ID: 32874007.
    Abstract:
    A Type 2 lepra reaction or erythema nodosum leprosum is an anticipated complication in the lepromatous spectrum of leprosy cases. It is an example of an immune complex-mediated complement activated disease (Type III hypersensitivity reaction). Hence, we tried to target the inflammatory mediators and the mental stressors for the possible management strategies.
    [Abstract] [Full Text] [Related] [New Search]